A randomized clinical trial to evaluate the efficacy of catecholamine surge supression by oral azilsartan in patients with hypertensive intracerebral hemorrhage
Phase 1
- Conditions
- Hypertensive intracerebral hemorrhage
- Registration Number
- JPRN-UMIN000014323
- Lead Sponsor
- Clinical Research Institute, Fujita Health University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Non-hypertensive ICH Those with disturbance of consciousness Those who did not give us consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chronological change in plasma levels of catecholamines, renin, and aldosterone
- Secondary Outcome Measures
Name Time Method Chronological changes in systemic blood pressure